Holen Sie sich die Stockscreener-App
24.09
1.51%
-0.37
Schlusskurs vom Vortag:
$24.46
Offen:
$24.54
24-Stunden-Volumen:
1.01M
Relative Volume:
1.11
Marktkapitalisierung:
$2.96B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
200.75
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
+0.54%
1M Leistung:
+3.97%
6M Leistung:
+8.32%
1J Leistung:
+38.85%
1-Tages-Spanne:
$24.05
$25.56
1-Wochen-Bereich:
$23.81
$25.56
52-Wochen-Spanne:
$16.47
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
24.09 | 3.00B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
296.28 | 49.30B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
91.66 | 15.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
73.26 | 13.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
88.59 | 7.73B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.64 | 7.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group Inc. stock momentum explainedJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
How Privia Health Group Inc. stock reacts to bond yields2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
State of Alaska Department of Revenue Acquires 5,223 Shares of Privia Health Group, Inc. $PRVA - Defense World
How moving averages guide Privia Health Group Inc. trading2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Using RSI to spot recovery in Privia Health Group Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Tools to assess Privia Health Group Inc.’s risk profileJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Privia Health Group Inc Stock Analysis and ForecastStock Market Trends & See Risk Factors Before Making Any Move - earlytimes.in
What momentum shifts mean for Privia Health Group Inc.Volume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Privia Health Group, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Privia Health Group, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Is Privia Health Group Inc a good long term investmentStock Correlation Metrics & AI Alerts You Can Actually Trust - earlytimes.in
Comparing Privia Health Group (NASDAQ:PRVA) & Healthcare Triangle (NASDAQ:HCTI) - Defense World
What drives Privia Health Group Inc stock priceMarket Entry Points & Optimize Entry & Exit With Smart Signals - earlytimes.in
What analysts say about Privia Health Group Inc stockGap Fill Strategies & Low Risk Trading Ideas - Early Times
Leerink Partnrs Issues Optimistic Forecast for PRVA Earnings - Defense World
M&A: Evolent Health Sells Primary Care Business to Privia Health for $113M - HIT Consultant
Piper Sandler Remains a Buy on Privia Health Group (PRVA) - The Globe and Mail
Leerink Partnrs Has Positive Outlook of PRVA FY2025 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Genfit SA (GNFT) and Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group, Inc. $PRVA Shares Sold by Riverbridge Partners LLC - MarketBeat
Leerink Partnrs Issues Positive Forecast for PRVA Earnings - Defense World
Citizens stock rating reiterated at Market Outperform by JMP By Investing.com - Investing.com Nigeria
Evolent Health selling primary care business to Privia Health - The Business Journals
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care - inkl
Visual trend scoring systems applied to Privia Health Group Inc.July 2025 Movers & Safe Capital Investment Plans - newser.com
Privia acquires Evolent’s value-based primary care unit for $100M - Healthcare Dive
PRVA: Stephens & Co. Reiterates Overweight Rating | PRVA Stock N - GuruFocus
Piper Sandler reiterates Overweight rating on Privia Health stock - Investing.com India
Privia Health Group's (PRVA) Overweight Rating Reiterated at Stephens - MarketBeat
Piper Sandler reiterates Overweight rating on Privia Health stock By Investing.com - Investing.com South Africa
3 Stocks That May Be Undervalued By Up To 43% - simplywall.st
Leerink Partnrs Has Strong Estimate for PRVA Q3 Earnings - MarketBeat
Privia Health Group: Hold Rating Amid Growth Prospects and Integration Risks Post-Evolent Health Acquisition - TipRanks
Evolent Health Divests Primary Care Business to Privia - MSN
Voya Investment Management LLC Sells 24,516 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Strs Ohio Purchases New Position in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health to acquire Evolent Health’s ACO business for $100 million By Investing.com - Investing.com Nigeria
Trust Point Inc. Has $596,000 Stock Position in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health Group to Acquire an Accountable Care Organization Business from Evolent Health - citybiz
Privia Health to acquire Evolent Health’s ACO business for $100 million - Investing.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.01%
3.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):